Skip to content

Meghana Koleti, MD

NPI 1942946223ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Providence, RI

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Providence, Rhode Island, licensed in RI and TX, with an NPI issued in May 2022. Part D covered 338 prescriptions written in 2024, 76% of them generic. Lilly USA, LLC was the largest of 2 companies reporting payments in 2025, $34.18 in all, mostly food and beverage.

Overview

NPI1942946223
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 9, 2022
Last updated in NPPESJul 2, 2025
Certified by providerJul 2, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (TX)

Part D prescriptions in 2024

Prescriptions (claims)338 · 518 30-day fills
Patients93
Total drug cost$68,935
Generic share76% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$34.18 · 2 payments from 2 companies
  • 2024$24.45 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Lilly USA, LLC$18.291
Novo Nordisk Inc$15.891

What the 2025 payments were for

  • Food and Beverage$34.18 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Providence

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Rhode Island →